Across TCGA pan-cancer cohorts, RNA5SP61 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNA5SP61’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where RNA5SP61 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP61 is over-expressed in tumor.
STAD and COAD are the cancer types where RNA5SP61 tumor–normal differential expression is most reproducible.